Cellectar stock climbs 8% on results for CNS malignancy therapy (NASDAQ:CLRB)
RapidEye Cellectar Biosciences (NASDAQ:CLRB) stock jumped 8% in midday trading Monday after it reported positive results from a Phase 2b ...
Tag: Cellectar
The latest news and updates about the AI Technology and Latest Tech Updates around the world... PouroverAI keeps you in the loop.